ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	32/196	191/7206	3.87384560813e-17
ko05340	Primary immunodeficiency	14/196	30/7206	7.57595651503e-15
ko04612	Antigen processing and presentation	17/196	77/7206	1.42947340963e-11
ko04650	Natural killer cell mediated cytotoxicity	18/196	97/7206	7.77098603235e-11
ko05168	Herpes simplex infection	24/196	182/7206	9.13879149616e-11
ko05320	Autoimmune thyroid disease	11/196	29/7206	1.02812921964e-10
ko05330	Allograft rejection	10/196	24/7206	2.48314174558e-10
ko05152	Tuberculosis	23/196	187/7206	9.52194890242e-10
ko04380	Osteoclast differentiation	19/196	134/7206	2.7346122874e-09
ko05164	Influenza A	21/196	167/7206	3.58621594021e-09
ko04621	NOD-like receptor signaling pathway	20/196	157/7206	6.8987632218e-09
ko05332	Graft-versus-host disease	8/196	18/7206	9.00444306392e-09
ko05140	Leishmaniasis	14/196	75/7206	9.95658192474e-09
ko04217	Necroptosis	21/196	178/7206	1.1466653618e-08
ko05162	Measles	17/196	120/7206	1.98112094064e-08
ko04659	Th17 cell differentiation	16/196	106/7206	2.08978601654e-08
ko04064	NF-kappa B signaling pathway	15/196	96/7206	3.64583390261e-08
ko05145	Toxoplasmosis	17/196	126/7206	4.17436941958e-08
ko04620	Toll-like receptor signaling pathway	15/196	100/7206	6.41615519441e-08
ko05321	Inflammatory bowel disease (IBD)	11/196	56/7206	2.32632467545e-07
ko04145	Phagosome	18/196	162/7206	3.38992293551e-07
ko04672	Intestinal immune network for IgA production	9/196	37/7206	4.36376387976e-07
ko04062	Chemokine signaling pathway	20/196	201/7206	4.49928597173e-07
ko04640	Hematopoietic cell lineage	11/196	64/7206	9.60431659126e-07
ko04940	Type I diabetes mellitus	8/196	32/7206	1.5594076493e-06
ko05310	Asthma	6/196	17/7206	3.61584174717e-06
ko04660	T cell receptor signaling pathway	14/196	124/7206	5.98473698456e-06
ko04658	Th1 and Th2 cell differentiation	12/196	96/7206	9.87781841583e-06
ko03050	Proteasome	9/196	54/7206	1.25005075607e-05
ko05150	Staphylococcus aureus infection	7/196	36/7206	4.22782596737e-05
ko04630	Jak-STAT signaling pathway	13/196	132/7206	5.63345439319e-05
ko05416	Viral myocarditis	8/196	55/7206	0.000105560891151
ko05144	Malaria	7/196	45/7206	0.000186819541521
ko04514	Cell adhesion molecules (CAMs)	12/196	130/7206	0.000202997313943
ko05167	Kaposi's sarcoma-associated herpesvirus infection	15/196	191/7206	0.000205178010562
ko05161	Hepatitis B	14/196	173/7206	0.000245368160855
ko05133	Pertussis	9/196	87/7206	0.000556210232702
ko05323	Rheumatoid arthritis	9/196	89/7206	0.000657812107463
ko04664	Fc epsilon RI signaling pathway	8/196	77/7206	0.00109507635076
ko04622	RIG-I-like receptor signaling pathway	7/196	62/7206	0.00137119490832
ko05142	Chagas disease (American trypanosomiasis)	10/196	130/7206	0.00276307524921
ko04210	Apoptosis	12/196	180/7206	0.00357783381695
ko04611	Platelet activation	11/196	163/7206	0.0047568793321
ko04666	Fc gamma R-mediated phagocytosis	9/196	122/7206	0.00585685900125
ko04670	Leukocyte transendothelial migration	10/196	151/7206	0.00795479750818
ko05166	HTLV-I infection	16/196	292/7206	0.00838110011812
ko05160	Hepatitis C	10/196	153/7206	0.00869571881756
ko04662	B cell receptor signaling pathway	7/196	88/7206	0.00979926865321
ko04510	Focal adhesion	1/196	240/7206	0.0230996664338
ko05131	Shigellosis	6/196	82/7206	0.0237676466769
ko05169	Epstein-Barr virus infection	11/196	206/7206	0.0277334414171
ko05016	Huntington's disease	1/196	215/7206	0.0315756507094
ko04080	Neuroactive ligand-receptor interaction	5/196	423/7206	0.0440527799049
ko04668	TNF signaling pathway	7/196	120/7206	0.0447624676503